clinical case - extend the benefit of immuno-oncology to more mibc patients: how do we do better?
Published 3 years ago • 368 plays • Length 20:07Download video MP4
Download video MP3
Similar videos
-
24:39
clinical case - immune check point inhibitor in the perioperative setting for mibc
-
30:23
lecture looking ahead - potential barriers to immune checkpoint inhibitors use in mibc
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
4:15
pathologists and pd-l1
-
3:35
cancer immunotherapy
-
1:02:33
immunology lecture 36: cancer immunology
-
10:44
6.5 - cancer: evading the immune system
-
3:10
immunology wars: monoclonal antibodies
-
34:32
new research in immuno-oncology
-
34:48
27: immuno-oncology 101 w/ elfirede nößner, helmholzzentrum, visiopharm advisor
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
5:45
systems immunology in immuno-oncology
-
19:03
next generation of immuno-oncology biomarkers
-
34:47
immuno-oncology, immune therapy, pd-1 in melanoma - omid hamid md
-
15:04
bite technology in immuno-oncology - summit 2021
-
1:26:01
advancing the application of immuno-oncology to improve patient care
-
5:03
tumour immunology and immunotherapy
-
3:27
immunotherapy: how the immune system fights cancer
-
18:43
lecture looking ahead - integrating immune checkpoint inhibitors into treatment paradigm for nmibc
-
31:23
clinical case - staging of high-risk pca
-
1:00:17
iclio webinar: immuno oncology management best practices 2 0
-
31:27
all you need for immuno-oncology b cell research [webinar]